Role of cell-cycle regulators in lung cancer
- 1 December 2005
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 205 (3), 319-327
- https://doi.org/10.1002/jcp.20424
Abstract
Lung cancer is the leading cause of cancer death worldwide. Histologically, 80% of lung cancers are classified as non-small-cell lung cancer (NSCLC), and the remaining 20% as small-cell lung cancer (SCLC). Lung carcinoma is the result of molecular changes in the cell, resulting in the deregulation of pathways controlling normal cellular growth, differentiation, and apoptosis. This review summarizes some of the most recent findings about the role of cell-cycle proteins in lung cancer pathogenesis and progression.Keywords
This publication has 75 references indexed in Scilit:
- pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysisOncogene, 2003
- Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplificationOncogene, 2002
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysisOncogene, 2002
- Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancersOncogene, 2000
- Prognostic factors in clinical stage I non–small cell lung cancerThe Annals of Thoracic Surgery, 1999
- Mechanisms of p16INK4A inactivation in non small-cell lung cancersOncogene, 1998
- Cancer Cell CyclesScience, 1996
- Molecular analysis of a family of cyclin‐dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non‐small cell lung cancersMolecular Carcinogenesis, 1995
- Cyclins, Cyclin-Dependent Kinases and Cdk Inhibitors: Implications in Cell Cycle Control and CancerCritical Reviews™ in Eukaryotic Gene Expression, 1995